Postdoctoral Fellow, Genomic Medicine Unit and Rare Neurological Diseases
Posted on: 27 Feb 2021
Framingham, MA
Job Description
Position Overview:
Sanofi’s Genomic Medicine Unit based in Framingham MA is looking for a highly qualified and motivated Postdoctoral Scientist to help develop novel therapies for the treatment of amyotrophic lateral sclerosis (ALS). The successful candidate will work closely with scientists in the Rare Neurological Disease cluster to establish iPSC derived glial and neuronal models of ALS to validate therapeutic targets and to understand disease biology. Expertise in cellular and molecular biology, sequencing and bioinformatics is highly desired.
Key Responsibilities:
Establish iPSC derived neuronal and glial models of ALS.
Implementation of multiple state-of-the-art techniques in molecular biology, biochemistry, and microscopy.
Work with cross functional teams to use omics, bioinformatics, data mining and other approaches to validate and identify targets.
Analyze, interpret, and present experimental results at lab meetings.
Publish/present findings in peer-reviewed journals/scientific conferences.
Maintain accurate records of experiments and analyses.
Maintain lucid and effective communication with manager and other colleagues.
Basic Qualifications:
Ph.D. in Neuroscience or related field, with at 0-2 years of postdoctoral training.
Previous first-author publication(s) in internationally recognized journals are required.
Ability to meet aggressive timelines and deliverables in a collaborative environment.
Excellent speaking, reading and writing skills.
Strong analytical and organizational skills.
Curiosity and a willingness to work independently.
Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
#GD-SA
#LI-SA
At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.
Sanofi Genzyme
Cambridge, MA
As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.
Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.
Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.
Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.
-
IndustryBiopharmaceuticals
-
No. of Employees14,000+
-
Website
-
Jobs Posted207
